Eric Fink
Human Resources Officer chez SILENCE THERAPEUTICS PLC
Profil
Eric Fink is currently the Chief Human Resources Officer at Silence Therapeutics Plc since 2022.
Prior to this, he was the Chief Human Resources Officer & Executive VP at Freeline Therapeutics Ltd.
from 2021 to 2022.
He also served as the Chief Human Resources Officer & Executive VP at Global Blood Therapeutics, Inc. from 2019 to 2021 and as Vice President-Human Resources at Jazz Pharmaceuticals, Inc. from 2018 to 2019.
Before that, he was an Associate Director-US Sales Training at Bayer HealthCare from 2008 to 2009.
Mr. Fink has a graduate degree from Mercyhurst University and an undergraduate degree from The Pennsylvania State University.
Postes actifs de Eric Fink
| Sociétés | Poste | Début |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Human Resources Officer | 01/02/2022 |
Anciens postes connus de Eric Fink
| Sociétés | Poste | Fin |
|---|---|---|
| FREELINE THERAPEUTICS HOLDINGS PLC | Human Resources Officer | 01/01/2022 |
| GLOBAL BLOOD THERAPEUTICS, INC. | Human Resources Officer | 01/05/2021 |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Human Resources Officer | 01/07/2019 |
Bayer HealthCare
 Bayer HealthCare Medical/Nursing ServicesHealth Services Part of Bayer AG, Bayer HealthCare is a private company that provides medical care and animal health care services. The company is based in Tarrytown, NY. | Corporate Officer/Principal | 01/12/2009 |
Freeline Therapeutics Ltd.
 Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Human Resources Officer | - |
Formation de Eric Fink
| Mercyhurst University | Graduate Degree |
| The Pennsylvania State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SILENCE THERAPEUTICS PLC | Commercial Services |
| Entreprise privées | 5 |
|---|---|
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
Bayer HealthCare
Bayer HealthCare Medical/Nursing ServicesHealth Services Part of Bayer AG, Bayer HealthCare is a private company that provides medical care and animal health care services. The company is based in Tarrytown, NY. | Health Services |
Freeline Therapeutics Ltd.
Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Health Technology |
Freeline Therapeutics Holdings Plc
 Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. It also develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Chunilal Nathwani in 2015 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
